Evidence map›Paper›PMID 30016324›Full record

ArticlePloS one2018

HIV-1 infection among crack cocaine users in a region far from the epicenter of the HIV epidemic in Brazil: Prevalence and molecular characteristics.

Divânia Dias da Silva França, Nativa Helena Alves Del-Rios, Megmar Aparecida Dos Santos Carneiro, Rafael Alves Guimarães, Karlla Antonieta Amorim Caetano, Monica Nogueira da Guarda Reis, Regina Maria Bringel Martins, Ana Rita Coimbra Motta-Castro, Mariane Martins de Araujo Stefani, Sheila Araujo Teles

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. HIV and Substance Use in Latin America: A Scoping Review.International journal of environmental research and public health · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Divânia Dias da Silva FrançaDepartment of Epidemiology, Municipal Secretary of Health of Goiânia, Goiás, Brazil.
Nativa Helena Alves Del-RiosInstitute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil.
Megmar Aparecida Dos Santos CarneiroInstitute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil.
Rafael Alves GuimarãesFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Karlla Antonieta Amorim CaetanoFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Monica Nogueira da Guarda ReisInstitute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil.
Regina Maria Bringel MartinsInstitute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil.
Ana Rita Coimbra Motta-CastroCenter of Biological and Health Sciences, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Mariane Martins de Araujo StefaniInstitute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil.
Sheila Araujo TelesFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.ORCID 0000-0002-7059-4241
Universidade Federal de Goiás · BRFundação de Apoio a Pesquisa do Estado de Goiás · BRUniversidade Federal de Mato Grosso do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brazil has the largest cocaine market in South America, and crack cocaine use is closely associated with HIV-1 infection. This study investigated the prevalence, risk factors, and HIV-1 subtypes, including recombinant forms and mutations associated with drug resistance, among crack cocaine users in Central-West Brazil. We recruited 600 crack cocaine users admitted to a referral hospital in Goiânia for psychiatric disorders. The participants were interviewed; blood samples were collected for anti-HIV-1/2 serological screening. HIV-1 pol gene sequences (entire protease [PR] and partial reverse transcriptase [RT]) were obtained from plasma RNA. HIV-1 subtypes, recombinant viruses, transmitted drug resistance (TDR), and secondary drug resistance mutations were investigated. The median participant age was 30 years (range, 18-68 years); most were male, single, unemployed, and of mixed races. Among them, 2.8% (17/600) were HIV-1 positive: 2.2% of men (11/507) and 6.5% of women (6/93). The main predictors of HIV-1 seropositivity were a sexual partner with HIV infection, irregular condom use, and previous homelessness. HIV-1 pol sequences (12/17) indicated the predominance of subtype B (n = 7), followed by recombinant forms FPR/BRT (n = 1) and BPR/FRT (n = 2) and subtypes F1 (n = 1) and C (n = 1). TDR prevalence was 58.3% (7/12). Isolates from two participants showed mutations associated with resistance to nucleoside reverse transcriptase inhibitors (NRTI) only (M41L, T125C, T125F, M184V), while an isolate from one patient who had received antiretroviral therapy (ART) since 2008 had a mutation associated with resistance to non-NRTI (G190S). Five isolates had secondary mutations to protease inhibitors (K20M, L10V, L33I, A71T, A71V). In conclusion, the findings of HIV-1 circulation, TDR to NRTI, and secondary mutations to protease inhibitors in ART-naïve crack cocaine users support the importance of monitoring this population in regions far from the epicenter of the HIV epidemic.

Indexed as

Crack CocaineHIV-1AdolescentAdultAgedBrazilDrug UsersFemaleGenetic VariationGenotypeHIV InfectionsHumansMaleMiddle AgedOdds RatioPhylogenyCrack Cocainepol Gene Products, Human Immunodeficiency Virus

Identifiers

PMID30016324
PMCPMC6049907
OpenAlexW2884274314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.